Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Other Working Capital Changes (2022 - 2025)

Coya Therapeutics' Other Working Capital Changes history spans 4 years, with the latest figure at $224625.0 for Q3 2025.

  • For Q3 2025, Other Working Capital Changes changed N/A year-over-year to $224625.0; the TTM value through Sep 2025 reached $2.5 million, up 19.75%, while the annual FY2024 figure was $4.9 million, 227.09% up from the prior year.
  • Other Working Capital Changes for Q3 2025 was $224625.0 at Coya Therapeutics, up from -$2.0 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $4.6 million in Q4 2024 and bottomed at -$2.0 million in Q2 2025.
  • The 4-year median for Other Working Capital Changes is -$42348.0 (2022), against an average of $374513.1.
  • The largest annual shift saw Other Working Capital Changes skyrocketed 2233.67% in 2023 before it tumbled 580.42% in 2025.
  • A 4-year view of Other Working Capital Changes shows it stood at $1.2 million in 2022, then skyrocketed by 51.56% to $1.8 million in 2023, then surged by 153.83% to $4.6 million in 2024, then crashed by 95.12% to $224625.0 in 2025.
  • Per Business Quant, the three most recent readings for COYA's Other Working Capital Changes are $224625.0 (Q3 2025), -$2.0 million (Q2 2025), and -$257884.0 (Q1 2025).